The Department of Molecular Biosciences at the University of Kansas invites applications for two faculty positions as tenure-track assistant or associate professors. One position is in the area of Biochemistry and another in the area of Microbial Pathogenesis. Candidates are expected to develop an internationally visible, rigorous, and well-funded research program and to effectively teach and mentor undergraduate and graduate students. Included for the Microbial Pathogenesis faculty position are specific resources and support mechanisms associated with the NIH Chemical Biology for Infectious Disease Center of Biomedical Research Excellence. As such, preference will be given to those applicants with current or future plans that incorporate an aspect of chemical biology into their research.
October 2017 News
Yinglong Miao (assistant professor) joins the Department of Molecular Biosciences faculty. Dr. Miao received his Ph.D. at the Indiana University in the lab of Peter Ortoleva. He subsequently completed his postdoctoral research with Jeremy Smith and Jerome Baudry at the University of Tennessee and Oak Ridge National Laboratory, where he studied drug-processing enzymes. He then moved to Andy McCammon’s lab at the Howard Hughes Medical Institute and University of California San Diego, where he worked on both method developments and applications in accelerated biomolecular simulations and drug discovery of the G-protein-coupled receptors. The Miao lab at KU will continue to work on biomolecular modeling, cellular signaling and computer-aided drug design. Welcome Dr. Miao!
Joanna Slusky (assistant professor) is the recipient of an NIH Director's New Innovator Award (DP2) for a proposal entitled "Designed Beta-Strands for Inhibiting Efflux Pumps and Disabling Antibiotic Resistance.” This program’s goal is to support a few exceptionally creative and promising early stage investigators who propose bold and highly innovative new research approaches and is part of the NIH High-Risk, High-Reward Research Program. Information about this Program which comprises four different types of awards can be found on the NIH website.
Mark Richter (professor) has been awarded an NIH Phase 2 SBIR grant in collaboration with Pinnacle Technology Inc. in Lawrence to develop a biosensor that measures the concentration of the neuroactive compound gamma-aminobutyric acid (GABA) in the brains of model animals. GABA is the major neuroinhibitory neurotransmitter in the brain and it plays a critical role in processes ranging from newborn seizures to anxiety, Alzheimer's, Huntington's, and Parkinson's diseases. The biosensor will measure changes in GABA concentration on a second by second basis in normal and diseased brains.